RNA based vaccine · VDDBV0128
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT04523571 | Phase 1 | COVID-19 |
| NCT04816643 | Phase 1 | COVID-19 |
| NCT04839315 | Phase 1 | COVID-19 |
| NCT04936997 | Phase 1 | COVID-19 |
| NCT04969601 | Phase 1 | COVID-19 |
| NCT04588480 | Phase 2 | COVID-19 |
| NCT04380701 | Phase 2 | COVID-19 |
| NCT04537949 | Phase 2 | COVID-19 |
| NCT04889209 | Phase 2 | COVID-19 |
| NCT04649021 | Phase 2 | COVID-19 |
| NCT04761822 | Phase 2 | COVID-19 |
| NCT04824638 | Phase 2 | COVID-19 |
| NCT04860739 | Phase 2 | COVID-19 |
| NCT04894435 | Phase 2 | COVID-19 |
| NCT04895982 | Phase 2 | COVID-19 |
| NCT04907331 | Phase 2 | COVID-19 |
| NCT04949490 | Phase 2 | COVID-19 |
| NCT04969263 | Phase 2 | COVID-19 |
| NCT05049226 | Phase 2 | COVID-19 |
| NCT05077254 | Phase 2 | COVID-19 |
| NCT04754594 | Phase 3 | COVID-19 |
| NCT05022329 | Phase 3 | COVID-19 |
| NCT05279365 | Phase 3 | COVID-19 |
| NCT04368728 | Phase 3 | COVID-19 |
| NCT04713553 | Phase 3 | COVID-19 |
| NCT04800133 | Phase 3 | COVID-19 |
| NCT04805125 | Phase 3 | COVID-19 |
| NCT04816669 | Phase 3 | COVID-19 |
| NCT04951323 | Phase 3 | COVID-19 |
| NCT05142319 | Phase 3 | COVID-19 |
| NCT05047640 | Phase 3 | COVID-19 |
| NCT05124171 | Phase 3 | COVID-19 |
| NCT05265065 | Phase 3 | COVID-19 |
| NCT04760132 | Approved | COVID-19 |
| NCT05060991 | Approved | COVID-19 |
| NCT04780659 | Approved | COVID-19 |
| NCT04961229 | Approved | COVID-19 |
| NCT04775069 | Approved | COVID-19 |
| NCT04852861 | Approved | COVID-19 |
| NCT04878211 | Approved | COVID-19 |
| NCT04955626 | Approved | COVID-19 |
| NCT04952766 | Approved | COVID-19 |
| NCT04969250 | Approved | COVID-19 |
| NCT05047718 | Approved | COVID-19 |
| NCT05057169 | Approved | COVID-19 |
| NCT05057182 | Approved | COVID-19 |
| NCT05075538 | Approved | COVID-19 |
| NCT05168709 | Approved | COVID-19 |
| NCT05170399 | Approved | COVID-19 |
| NCT05160766 | Approved | COVID-19 |
| NCT05329064 | Approved | COVID-19 |
| NCT05212610 | Approved | COVID-19 |
| NCT05231005 | Approved | COVID-19 |